Background: Metabolic bariatric surgery (MBS) has been shown to provide significant improvements in metabolic dysfunction-associated steatotic liver disease (MASLD) but its effects on liver fibrosis remain controversial.
Aims: To establish a rodent model of liver fibrosis progression after MBS and to investigate the impact of post-operative diets and different bypass lengths on liver fibrosis progression, weight dynamics, and metabolic effects.
Methods: Male Sprague Dawley rats were subjected to either sham surgery or one anastomosis gastric bypass (OAGB) with moderate or extended biliopancreatic limb lengths, followed by dietary manipulation with a high-fat, high-fructose and high-cholesterol diet (FFC) or standard chow.
Laparoscopic Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S) is a bariatric/metabolic procedure that has been gaining popularity in recent years. SADI-S strongly affects the secretion of various gut hormones, adipocytokines and incretins. From a mechanistic point of view, the operation combines malabsorption and restriction, and has been shown to have a long-lasting and significant impact on weight loss and remission of comorbidities.
View Article and Find Full Text PDFSurg Technol Int
October 2021
Laparoscopic diverted one-anastomosis gastric bypass (D-OAGB) is a bariatric procedure combining the principles of restriction, malabsorption, and other factors to induce weight loss. It is achieved by creating a narrow, long gastric pouch and bypassing a part of the small bowel (biliopancreatic limb). D-OAGB was first described by Dr.
View Article and Find Full Text PDF